Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 1.00 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 1.00 |
| ▸ | ERN1 | O75460 | 5/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | CDK4 | P11802 | 1/20 | 0.60 |
| ▸ | CCND1 | P24385 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.54 |
| ▸ | JUN | P05412 | 1/20 | 0.54 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicyladehyde SCHEMBL29386538 | 1.00 | — | — | |
| Salicyladehyde SCHEMBL15395 | 1.00 | — | — | |
| Salicyladehyde SCHEMBL4456334 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 | |
| Salicyladehyde SCHEMBL6151947 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 | |
| Salicyladehyde SCHEMBL6851494 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 | |
| Salicyladehyde SCHEMBL23389487 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 | |
| Salicyladehyde SCHEMBL5842615 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 | |
| Salicyladehyde SCHEMBL5121332 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 | |
| Salicyladehyde SCHEMBL1176891 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 | |
| Salicyladehyde SCHEMBL23628380 | 0.97 | TRIM24 (0.95) | TRIM24TRIM33ERN1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112585152-A | Electrically readable read-only memory based on nucleic acids | 加利福尼亚大学董事会 | 2021-03-30 | — | — | CN | disclosed |
| CN-103408458-B | Bridged dialdehyde beta-amino alcohol acetal tetradentate two-chiral-center Schiff base compounds with, synthesis thereof and applications thereof | UNIV ZHEJIANG TECHNOLOGY | 2015-04-22 | — | — | CN | disclosed |
| EP-2788496-A1 | METHOD OF DIAGNOSING PNEUMONIA BY DETECTING A VOLATILE ORGANIC COMPOUND | Meon Medical Solutions GmbH & Co. KG (AT) | 2014-10-15 | — | — | EP | disclosed |
| CN-103408458-A | Bridged dialdehyde beta-amino alcohol acetal tetradentate two-chiral-center Schiff base compounds with, synthesis thereof and applications thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-11-27 | — | — | CN | disclosed |
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | disclosed |
| WO-2013083518-A1 | METHOD OF DIAGNOSING PNEUMONIA BY DETECTING A VOLATILE ORGANIC COMPOUND | MEON MEDICAL SOLUTIONS GMBH & COKG (AT) | 2013-06-13 | — | — | WO | disclosed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | disclosed |
| US-7109211-B2 | Substituted benzopyran derivatives for the treatment of inflammation | PHARMACIA CORPORATION (OF PFIZER, INC.) (US) | 2006-09-19 | — | — | US | disclosed |
| US-20050049252-A1 | Substituted benzopyran derivatives for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2005-03-03 | — | — | US | disclosed |
| US-6417195-B1 | LIBRARIES AND COMBINATORIAL CHEMISTRY | LION BIOSCIENCE AG (DE) | 2002-07-09 | — | — | US | disclosed |
| US-5874443-A | BIOSYNTHESIS | TREGA BIOSCIENCES, INC. (US) | 1999-02-23 | — | — | US | disclosed |
| US-4087402-A | USED FOR TREATMENT OF INORGANIC FILLERS | KENRICH PETROCHEMICALS, INC. (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049252-A1 | Substituted benzopyran derivatives for the treatment of inflammation | PTGES2, PTGS2, PTGER2 | TRIM24 3726/4885TRIM33 3978/4885ERN1 2554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.